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LETTERS
Mycobacterium 
haemophilum: 
Emerging or 
Underdiagnosed 
in Brazil?
To the Editor: Mycobacterium
haemophilum was first described in
1978 by Sompolinsky et al. (1) as the
cause of cutaneous infections in a
patient with Hodgkin disease. Since
then, fewer than 100 cases have been
reported worldwide, mostly among
immunocompromised patients (2),
although  M. haemophilum infection
has also been described in immuno-
competent patients as the cause of cer-
vical, submandibular, and  perihilar
lymphadenopathy in children and of
pulmonary nodules in an adult (3–5).
Cases have been reported from United
States, Australia, Canada, France,
Israel, and the United Kingdom, but to
date no reports have originated in
South America.
The most frequent clinical sign of
M. haemophilum infection in adults is
a skin or joint lesion. Less common
sites for isolation of M. haemophilum
include the respiratory tract, blood,
bone marrow, bone, and central
venous catheters (2,6). M. haemophi-
lum is unique among Mycobacterium
species owing to its special growth
requirements: it grows best at 30°C
and requires an iron supplement
(hemin or ferric ammonium citrate). 
We report here the characterization
of three strains of M. haemophilum
isolated from patients living in three
states in two distinct regions of Brazil,
Rio de Janeiro and São Paulo (south-
east region) and Bahia (northeast
region). The first strain was detected
in Rio de Janeiro in December 2000
from a blood culture of a 67-year-old
man who had received a kidney trans-
plant in 1988 at the age of 55 years
and was undergoing immunosuppres-
sive treatment with prednisolone and
mycophenolate mofetil. The second
strain was detected in São Paulo in
March 2001 in a 43-year-old HIV-
seropositive man from a biopsied
specimen of a nasal ulcer. A direct
acid-fast stain showed many acid-fast
bacilli. At time of diagnosis, the
patient’s CD4+ cell count was 8/mm3
and his viral load was 290.000 copies/
mL. The third isolate was detected in
Bahia in a 30-year-old HIV-seroposi-
tive man who had osteomyelitis in an
elbow. A direct acid-fast stain showed
rare acid-fast bacilli.
The isolate from the Rio de Jan-
eiro patient grew only in Myco/F Lytic
media (Becton Dickinson Microbiol-
ogy Systems, Sparks, MD) plus blood
in primary isolation and subculture; it
failed to grow on chocolate agar at
30°C after 6 weeks. The isolates from
São Paulo and Bahia showed a slight
growth in 12B media on primary iso-
lation; this growth was likely sup-
ported by the iron provided by the
biopsied tissue. Subcultures on choco-
late agar showed good growth after 2–
3 weeks at 30°C. The isolates did not
grow on Middlebrook 7H10 agar
without hemin and grew on the same
media when supplemented with 60
MM of hemin. Both strains showed a
negative catalase reaction.
The species of all isolates was
identified through polymerase chain
reaction amplification of the gene
encoding for the 65-kDa heat shock
protein, followed by restriction analy-
sis with the enzymes BstEII and
HaeIII as described by Telenti et al.
(7), with minor modifications. The
three isolates showed the same restric-
tion pattern as that obtained for M.
haemophilum American Type Culture
Collection 29548 prototype strain. Iso-
lates from Rio de Janeiro and São
Paulo were also molecularly charac-
terized as previously described by
Roth et al. (8), corroborating M. hae-
mophilum species identification. 
To our knowledge, these M. hae-
mophilum isolates are the first to be
reported in Brazil. These three patients
came from cities 429–962 km apart,
demonstrating the dispersion of M.
haemophilum infection in Brazil.
Given the specific requirements of M.
haemophilum for its growth in culture,
our findings suggest that its true inci-
dence in Brazil is greatly underesti-
mated. Consequently, we strongly
recommend that clinical laboratories
in Brazil include an iron-supple-
mented medium, such as chocolate
agar, incubated at 30ºC, for primary
isolation of Mycobacterium spp in
samples from selected patients.
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Children and 
Multidrug-Resistant 
Tuberculosis in 
Mumbai (Bombay), 
India
To the Editor: India has the high-
est number of tuberculosis (TB) cases
in the world. Each year in India, over
2 million new cases of TB are diag-
nosed, and approximately 500,000
persons die of the disease (1). During
the last decade, multidrug-resistant TB
has burgeoned in India, resulting in an
extremely large number of multidrug-
resistant TB cases, second only to the
number of cases noted in Latvia (2).
Since 1993, in response to this epi-
demic, the government of India has
implemented the Revised National
Tuberculosis Control Program, which
is based on directly observed treat-
ment (short course) principles (1).
Mumbai (formerly Bombay),
India, is a densely populated metropo-
lis with a population of approximately
12 million, 4.8 million (40%) of
whom reside in overcrowded slums.
Since 1990, a resurgence of TB has
occurred, characterized by a 70% to
140% increase in the rate of TB-
related deaths among adults aged 25–
44 years (3). A vital factor contribut-
ing to this phenomenon is HIV infec-
tion. A recent review of autopsy
reports from Mumbai showed that 85
(59%) of 143 adult patients with AIDS
were diagnosed with pulmonary TB
(4), indicating that the disease is the
most common opportunistic infection
for persons with AIDS. Commensu-
rate with the increase in TB cases is a
surge in the prevalence of multidrug-
resistant TB in adult patients. Two ref-
erence mycobacterial laboratories in
private hospitals in Mumbai have
reported a high prevalence of multi-
drug-resistant TB strains; 56 (11%) of
521 cases in 1991–1995, and 58 (58%)
of 100 cases in 1994–1995 (5,6).
The crisis of multidrug-resistant
TB in adults in Mumbai has been well
documented (7). However, little atten-
tion has been directed at children also
affected by the resurgent TB epi-
demic. We think that TB is developing
in more children in Mumbai today
than a decade earlier. Moreover, close
proximity to adult patients with multi-
drug-resistant TB makes children
prone to developing primary multi-
drug-resistant TB, a vulnerability doc-
umented in a South African study (8).
Similarly, disseminated TB is occur-
ring in large numbers of children liv-
ing in overcrowded slums in Mumbai
with a consequent high death rate (9);
we attribute many of these deaths in
children to primary multidrug-resis-
tant TB. However, this conclusion is
difficult to document, as most affected
children are sputum-negative for acid-
fast bacilli. Contact tracing to detect
the adult source of infection is rou-
tinely undertaken; often we can trace
the source of infection. Because the
facilities for culture and susceptibility
testing are not available at affordable
rates, proving that the adult contact
has multidrug-resistant TB is not fea-
sible in most cases.
The AIDS epidemic in adults in
Mumbai has adversely affected the
epidemic within the population of
children with TB. HIV infection in
young adults has resulted in a large
number of HIV-infected infants, the
result of a lack of any large-scale pro-
gram aimed at preventing vertical
transmission. To combat the growing
problem with HIV-infected infants,
India’s National AIDS Control Orga-
nization is performing feasibility stud-
ies for implementing interventions to
prevent mother-to-child transmission
of HIV infection. Clinical trials with
nevirapine are currently being con-
ducted at five major public hospitals
in Mumbai. 
Multidrug-resistant TB frequently
develops in adult AIDS patients (7).
Accordingly, many pediatric AIDS
patients in Mumbai are also develop-
ing primary multidrug-resistant TB.
Since most families cannot afford anti-
retroviral therapy, HIV-infected chil-
dren in whom TB is diagnosed are
prescribed a four-drug TB treatment
(consisting of isoniazid, rifampicin,
pyrazinamide, and ethambutol) and
co-trimoxazole for Pneumocystis cari-
nii pneumonia prophylaxis. Although
deaths in these children are being
attributed to AIDS, we think that
many of these deaths are related to
multidrug-resistant TB. 
To combat the TB epidemic, the
Revised National Tuberculosis Con-
trol Program directly observed treat-
ment strategy has been implemented
as part of a public health program.
However, most patients receive treat-
ment from private physicians and thus
remain outside the purview of the
strategy. Private physicians seldom
refer their patients to centers offering
directly observed treatments because
of potential for loss of income (3). In
1991, Uplekar and Shepard (10)
reported that 100 private physicians in
the Dharavi slums in Mumbai pre-
scribed 80 different anti-TB regimens;
most were both inappropriate and
expensive. Since private physicians
have not yet been involved in the gov-